Drug Type Recombinant polypeptide, Biosimilar |
Synonyms 利鲁平 |
Target |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CN (28 Mar 2023), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Obesity | CN | 30 Jun 2023 | |
Overweight | CN | 30 Jun 2023 | |
Diabetes Mellitus, Type 2 | CN | 28 Mar 2023 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Phase 3 | CN | 21 Jul 2020 |